Fibroblast growth factors (FGFs) signal in a paracrine or endocrine fashion to mediate a
myriad of biological activities, ranging from issuing developmental cues, maintaining tissue …

Policymakers must make management decisions despite incomplete knowledge and
conflicting model projections. Little guidance exists for the rapid, representative, and unbiased …

Receptor tyrosine kinases (RTKs) exhibit basal tyrosine phosphorylation and activity in the
absence of ligand stimulation, which has been attributed to the “leaky” nature of tyrosine …

Fibroblast growth factor 21 (FGF21) is an endocrine-acting hormone that has the potential to
treat metabolic diseases, such as type 2 diabetes and obesity. Development of FGF21 into a …

Importance Identifying which patients with COVID-19 are likely to benefit from COVID-19
convalescent plasma (CCP) treatment may have a large public health impact. Objective To …

Policymakers make decisions about COVID-19 management in the face of considerable
uncertainty. We convened multiple modeling teams to evaluate reopening strategies for a mid-…

As part of the US Food and Drug Administration (FDA)’s Prescription Drug User Fee Act (PDUFA)
VI commitments, the Center for Biologics Evaluation and Research (CBER) and Center …

Background Blood transfusions are a vital component of modern healthcare, yet adverse
reactions to blood product transfusions can cause morbidity, and rarely result in mortality. …

… assay is associated with modest clinical efficacy - Belov - 2022 - American Journal of
Hematology - Wiley Online Library … Artur Belov and Yin Huang contributed equally to this study. …

Background Transfusion‐related adverse events can be unrecognized and unreported. As
part of the US Food and Drug Administration's Center for Biologics Evaluation and Research …